Olfactory outcomes in the management of aspirin exacerbated respiratory disease related chronic rhinosinusitis.

World J Otorhinolaryngol Head Neck Surg · 2020 · PMC7729240 · PMID 33336175

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

did not reach statistical significanceno p-value reported

38 Two additional case series also demonstrate improvement in patient reported olfaction, which did not reach statistical significance. 36 , 37 Mepolizumab, an anti-IL-5 human monoclonal antibody, was studied in 14 patients with AERD.

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.